Consulting

Commercial strategy for life sciences founders, grounded in how the science and regulation actually move.

What we do

The right answer depends on the science.

We work with pre-seed to seed biotech, healthtech, and medtech companies to answer the commercial questions that generalist advice can't — because the right answer depends on regulatory pathway timing, pipeline stage, and deal-structure mechanics specific to your science.

What this typically looks like

Depth, not breadth.

Who we work with

Built for scientist founders.

Pre-seed to seed, post-institutional-funding companies led by scientist or technical founders with no in-house commercial function. If you have a decision where the regulatory or pipeline reality changes the right commercial answer, that's exactly where we help.

How an engagement works

Eight weeks, start to finish.

Week 1

Scoping

We align with you on the problem, timeline, and deliverables.

Week 4

Mid-project check-in

We review progress and gather feedback to ensure we're on track.

Weeks 5–7

Development

Our team conducts deep research, analysis, and synthesis.

Week 8

Final presentation

You receive a written report and a presentation of findings and recommendations.

Cost

Discussed, not listed.

Scope and cost depend on the nature of the engagement, and are discussed directly before we begin. No fixed price list, no implied figure.

In their words

What founders take away from an engagement with us.

See the project work

The thoroughness of the analysis demonstrated a real depth of understanding. This was extremely well-delivered and will directly impact our plans moving forward.

Alison Quinn

Alison Quinn, Co-Founder & CEO, Respiro Diagnostics

Paul Riley

Dr Paul Riley

Senior Advisor

Nexcea Life Sciences Consultancy

Our work is supported by Dr Paul Riley, Founder of Nexcea Life Sciences Consultancy, who serves as Senior Advisor to NBS.

Meet the Team

Our Latest Projects